Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Brotchi

Showing results (191-200 of 201) with videos related to

Pageof 21
Sort By:
Glia|December 18, 2001
Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic featuresN Belot, S Rorive, I Doyen, et al.
Experimental Neurology|January 16, 2007
Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vectorA Chtarto, X Yang, O Bockstael, et al.
Journal of Neuropathology and Experimental Neurology|August 28, 1998
Characterization of astroglial versus oligodendroglial phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer-assisted microscopyC Decaestecker, I Camby, L Gordower, et al.
Journal of Neurosurgery|January 6, 2001
Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: early experience with brain tumors. Technical noteM Levivier, D Wikier, S Goldman, et al.
Journal of Neurobiology|November 25, 1998
Gastrin inhibits motility, decreases cell death levels and increases proliferation in human glioblastoma cell linesC De Hauwer, I Camby, F Darro, et al.
Neuropathology and Applied Neurobiology|March 29, 2000
Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumoursI Camby, F Lefranc, G Titeca, et al.
Stereotactic and Functional Neurosurgery|January 1, 1997
Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patientsM Levivier, S Dethy, F Rodesch, et al.
Brain Pathology (Zurich, Switzerland)|January 6, 2001
Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migrationI Camby, N Belot, S Rorive, et al.
Brain Pathology (Zurich, Switzerland)|February 16, 1999
Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteinsI Camby, N Nagy, M B Lopes, et al.
American Journal of Orthopedics (Belle Mead, N.J.)|March 20, 1998
Clinical assessment of a novel antiadhesion barrier gel: prospective, randomized, multicenter, clinical trial of ADCON-L to inhibit postoperative peridural fibrosis and related symptoms after lumbar discectomyN de Tribolet, F Porchet, T W Lutz, et al.
Pageof 21

Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
Glia|December 18, 2001
Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic featuresN Belot, S Rorive, I Doyen, et al.
Experimental Neurology|January 16, 2007
Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vectorA Chtarto, X Yang, O Bockstael, et al.
Journal of Neuropathology and Experimental Neurology|August 28, 1998
Characterization of astroglial versus oligodendroglial phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer-assisted microscopyC Decaestecker, I Camby, L Gordower, et al.
Journal of Neurosurgery|January 6, 2001
Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: early experience with brain tumors. Technical noteM Levivier, D Wikier, S Goldman, et al.
Journal of Neurobiology|November 25, 1998
Gastrin inhibits motility, decreases cell death levels and increases proliferation in human glioblastoma cell linesC De Hauwer, I Camby, F Darro, et al.
Neuropathology and Applied Neurobiology|March 29, 2000
Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumoursI Camby, F Lefranc, G Titeca, et al.
Stereotactic and Functional Neurosurgery|January 1, 1997
Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patientsM Levivier, S Dethy, F Rodesch, et al.
Brain Pathology (Zurich, Switzerland)|January 6, 2001
Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migrationI Camby, N Belot, S Rorive, et al.
Brain Pathology (Zurich, Switzerland)|February 16, 1999
Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteinsI Camby, N Nagy, M B Lopes, et al.
American Journal of Orthopedics (Belle Mead, N.J.)|March 20, 1998
Clinical assessment of a novel antiadhesion barrier gel: prospective, randomized, multicenter, clinical trial of ADCON-L to inhibit postoperative peridural fibrosis and related symptoms after lumbar discectomyN de Tribolet, F Porchet, T W Lutz, et al.
Pageof 21